Attached files
file | filename |
---|---|
EX-21 - EXHIBIT 21.1 - Vaxart, Inc. | ex21-1.htm |
EX-23 - EXHIBIT 23.1 - Vaxart, Inc. | ex23-1.htm |
EX-23 - EXHIBIT 23.1A - Vaxart, Inc. | ex23-1a.htm |
EX-31 - EXHIBIT 31.1 - Vaxart, Inc. | ex31-1.htm |
EXCEL - IDEA: XBRL DOCUMENT - Vaxart, Inc. | Financial_Report.xls |
10-K - FORM 10-K - Vaxart, Inc. | bota20140630_10k.htm |
Exhibit 32.1
Certification Pursuant To Section 906 of the
Sarbanes-Oxley Act 2002
In connection with the Annual Report on Form 10-K of Biota Pharmaceuticals, Inc. (the "Company") for the year ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned hereby certifies, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:
1. The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Russell H. Plumb
-----------------------------------------------------
President, Chief Executive Officer, Chief Financial Officer, (Principal Executive Officer and Principal Financial Officer)
September 30, 2014